Using Open Contest and Neuro-influence Experiment to Develop and Evaluate PrEP Promotion Messages for High Risk Men
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04166851|
Recruitment Status : Not yet recruiting
First Posted : November 18, 2019
Last Update Posted : November 18, 2019
|Condition or disease||Intervention/treatment||Phase|
|HIV/AIDS||Behavioral: PrEP campaign messages developed via open contest Behavioral: PrEP campaign messages developed via social marketing approach||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||60 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Triple (Participant, Investigator, Outcomes Assessor)|
|Official Title:||Using Open Contest and Neuro-influence Experiment to Develop and Evaluate PrEP Promotion Messages for High Risk Men|
|Estimated Study Start Date :||November 15, 2019|
|Estimated Primary Completion Date :||August 31, 2020|
|Estimated Study Completion Date :||February 28, 2021|
Experimental: Open contest messages
Participants will view the top PrEP-promotion messages developed via an open contest.
Behavioral: PrEP campaign messages developed via open contest
PrEP campaign messages will be developed via an open contest in Baltimore.
Active Comparator: Social marketing messages
Participants will view the PrEP-promotion messages developed via social marketing.
Behavioral: PrEP campaign messages developed via social marketing approach
PrEP campaign messages developed with a traditional social marketing approach.
- change of neural activity [ Time Frame: 20 seconds between participants start and finish reviewing the messages ]change of the ratio of oxygenated (O2HB) to deoxygenated (HHB) hemoglobin in the Medial Prefrontal Cortex (MPFC) regions measured by functional near infrared spectroscopy (fNIRS)
- change of willingness and behavioral intention to take PrEP [ Time Frame: 60 days between baseline and follow up ]questions on willingness and behavioral intention to take PrEP. Participants will be asked, "Suppose that PrEP is at least 90% effective in preventing HIV when taken daily. How likely would you be to take PrEP if it were available for free?" with responses ranging from "I would definitely take it" to "I would definitely not take it." Participants will be asked, "PrEP is currently available with a prescription from your doctor and research has shown that a majority of insurance companies cover most or all of the costs of PrEP. Do you plan to begin PrEP?" Response options range from "Yes, I will definitely begin taking PrEP" to "No, I definitely will not begin taking PrEP."
- PrEP action and initiation [ Time Frame: 60-day follow up ]questions on "Have you spoken with a provider about PrEP during the past 30 days?" and "Have you started taking PrEP during the past 30 days?"
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04166851
|Contact: Cui Yang, PhDfirstname.lastname@example.org|
|United States, Maryland|
|Johns Hopkins Bloomberg School of Public Health|
|Baltimore, Maryland, United States, 21205|
|Contact: Cui Yang, PhD 410-502-5368 email@example.com|
|Principal Investigator:||Cui Yang, PhD||Johns Hopkins Bloomberg School of Public Health|